Adhansia XR from Adlon Therapeutics is a long-acting central nervous system stimulant indicated for attention deficit hyperactivity disorder (ADHD) in children aged 6 and older. Adlon recently announced that in a clinical trial, ADHD patients had a significant improvement in symptoms starting after one hour after taking the drug and up to 16 hours. Adlon recently…

The Galien Foundation has revealed its latest nominees for the 2021 Prix Galien USA Award highlighting innovations in biotechnology, pharmaceutical agents, medical technology and digital health products. Entrants to the competition must have received FDA approval within the past five years and demonstrate exceptional therapeutic potential. The Galien Foundation does not use financial data to…

The Galien Foundation recently announced nominees for most innovative pharmaceutical agents for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical, pharmaceutical drugs and medical technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien…